The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

Aficamten, a first-in-class cardiac myosin inhibitor, offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed ...

Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...

The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's cholesterol pill ...

Buying medicines can get confusing because the same tablet or syrup is often sold under different names and prices. Medicines ...

Learn how Costco pharmacy handles pricing, insurance, delivery, and pet meds so you can decide if switching will save you ...

A post on Instagram by a doctor advising about the adequate measures to be taken to save a person showing heart-attack ...

Although taking potent statins may increase blood sugar levels for some people, their benefits may outweigh risks when managing cholesterol.

Vitamin D supplements may lower cholesterol, but the evidence is mixed. Avoiding high doses of vitamin D can prevent nausea and kidney stones.

A massive recall of atorvastatin, a widely used cholesterol drug, has raised serious concerns about drug quality and FDA oversight. Despite a prior sanction for substandard manufacturing, a global ...